risedronic acid has been researched along with Hearing Loss in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanzaki, S | 1 |
| Takada, Y | 1 |
| Ogawa, K | 1 |
| Matsuo, K | 1 |
1 other study available for risedronic acid and Hearing Loss
| Article | Year |
|---|---|
Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin.
Topics: Animals; Bone Density Conservation Agents; Cochlea; Diphosphonates; Etidronic Acid; Evoked Potential | 2009 |